BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16601670)

  • 1. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
    Hachem JP; Wagberg F; Schmuth M; Crumrine D; Lissens W; Jayakumar A; Houben E; Mauro TM; Leonardsson G; Brattsand M; Egelrud T; Roseeuw D; Clayman GL; Feingold KR; Williams ML; Elias PM
    J Invest Dermatol; 2006 Jul; 126(7):1609-21. PubMed ID: 16601670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome.
    Descargues P; Deraison C; Prost C; Fraitag S; Mazereeuw-Hautier J; D'Alessio M; Ishida-Yamamoto A; Bodemer C; Zambruno G; Hovnanian A
    J Invest Dermatol; 2006 Jul; 126(7):1622-32. PubMed ID: 16628198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
    Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A; Deraison C; Bonnart C; Bitoun E; Robinson R; O'Brien TJ; Wakamatsu K; Ohtsubo S; Takahashi H; Hashimoto Y; Dopping-Hepenstal PJ; McGrath JA; Iizuka H; Richard G; Hovnanian A
    J Invest Dermatol; 2005 Feb; 124(2):360-6. PubMed ID: 15675955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
    Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
    J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.
    Briot A; Deraison C; Lacroix M; Bonnart C; Robin A; Besson C; Dubus P; Hovnanian A
    J Exp Med; 2009 May; 206(5):1135-47. PubMed ID: 19414552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.
    Descargues P; Deraison C; Bonnart C; Kreft M; Kishibe M; Ishida-Yamamoto A; Elias P; Barrandon Y; Zambruno G; Sonnenberg A; Hovnanian A
    Nat Genet; 2005 Jan; 37(1):56-65. PubMed ID: 15619623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules.
    Shimomura Y; Sato N; Kariya N; Takatsuka S; Ito M
    Br J Dermatol; 2005 Nov; 153(5):1026-30. PubMed ID: 16225619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netherton syndrome: report of two Taiwanese siblings with staphylococcal scalded skin syndrome and mutation of SPINK5.
    Chao SC; Richard G; Lee JY
    Br J Dermatol; 2005 Jan; 152(1):159-65. PubMed ID: 15656819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins.
    Di WL; Hennekam RC; Callard RE; Harper JI
    Br J Dermatol; 2009 Aug; 161(2):404-12. PubMed ID: 19438860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEKTI-1 in sickness and in health.
    Roelandt T; Thys B; Heughebaert C; De Vroede A; De Paepe K; Roseeuw D; Rombaut B; Hachem JP
    Int J Cosmet Sci; 2009 Aug; 31(4):247-54. PubMed ID: 19467033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.
    Igawa S; Kishibe M; Minami-Hori M; Honma M; Tsujimura H; Ishikawa J; Fujimura T; Murakami M; Ishida-Yamamoto A
    J Invest Dermatol; 2017 Feb; 137(2):449-456. PubMed ID: 27769847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.
    Ong C; O'Toole EA; Ghali L; Malone M; Smith VV; Callard R; Harper JI
    Br J Dermatol; 2004 Dec; 151(6):1253-7. PubMed ID: 15606522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When activity requires breaking up: LEKTI proteolytic activation cascade for specific proteinase inhibition.
    Furio L; Hovnanian A
    J Invest Dermatol; 2011 Nov; 131(11):2169-73. PubMed ID: 21997416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
    Komatsu N; Takata M; Otsuki N; Ohka R; Amano O; Takehara K; Saijoh K
    J Invest Dermatol; 2002 Mar; 118(3):436-43. PubMed ID: 11874482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proinflammatory role of KLK6 protease in Netherton syndrome.
    Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
    J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Park NJ; Jo BG; Bong SK; Park SA; Lee S; Kim YK; Yang MH; Kim SN
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
    J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of corneodesmosome degradation and lamellar granule transportation in the desquamation process.
    Ishida-Yamamoto A; Kishibe M
    Med Mol Morphol; 2011 Mar; 44(1):1-6. PubMed ID: 21424930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.